Literature DB >> 29134380

Radioactive Seed Localization Versus Wire Localization for Nonpalpable Breast Lesions: A Two-Year Initial Experience at a Large Community Hospital.

Lacey Stelle1, Taylor Schoenheit2, Allison Brubaker2, Xiwei Tang2, Peiyong Qu2, Kimberly Cradock1, Anna Higham3.   

Abstract

BACKGROUND: Radioactive seed localization (RSL) is a safe and effective alternative to wire localization (WL) for nonpalpable breast lesions. While several large academic institutions currently utilize RSL, few community hospitals have adopted this technique.
OBJECTIVE: The aim of this study was to examine the experience of RSL versus WL at a large community hospital.
METHODS: A retrospective chart review of patients who underwent RSL or WL for breast-conserving surgery from 1 November 2013 to 31 November 2015.
RESULTS: The total number of lesions examined was 382. RSL was utilized in 205 (54%) lesions, with 187 undergoing single RSL, while WL was used in 155 (40%) lesions, with 109 undergoing single WL; both techniques were used in 22 (6%) lesions. Pathology was benign in 142 (48%) lesions, with 93 RSLs and 49 WLs. For malignant lesions, mean specimen size was 36.3 g for single RSL and 35.9 g for single WL (p = 0.904). Re-excision for margin clearance was required for 16 (17%) malignant lesions in the RSL group and 10 (17%) in the WL group (p = 0.954). For malignant lesions, mean operating room time was 86 min for single RSL versus 70 min for single WL (p = 0.014).
CONCLUSIONS: The use of RSL is a viable option in the community setting, with several benefits over WL. While operative times were slightly longer with RSL, there was no difference in specimen size or re-excision rate for malignant lesions.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29134380     DOI: 10.1245/s10434-017-6102-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  1 in total

1.  A multicenter prospective cohort study to evaluate feasibility of radio-frequency identification surgical guidance for nonpalpable breast lesions: design and rationale of the RFID Localizer 1 Trial.

Authors:  Bianca M den Dekker; Anke Christenhusz; Thijs van Dalen; Lisa M Jongen; Margreet C van der Schaaf; Anneriet E Dassen; Ruud M Pijnappel
Journal:  BMC Cancer       Date:  2022-03-22       Impact factor: 4.430

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.